Oracle
ORCL
Salesforce
CRM
Microsoft
MSFT
Cisco
CSCO
Broadcom
AVGO
US Stock MarketDetailed Quotes
NRIX Nurix Therapeutics
- 19.510
- +0.610+3.23%
Close Jan 8 16:00 ET
- 19.510
- 0.0000.00%
Post 16:20 ET
1.38BMarket Cap-6.73P/E (TTM)
19.740High18.720Low860.93KVolume18.810Open18.900Pre Close16.66MTurnover1.49%Turnover RatioLossP/E (Static)70.84MShares29.56052wk High3.67P/B1.13BFloat Cap7.65052wk Low--Dividend TTM57.74MShs Float52.380Historical High--Div YieldTTM5.40%Amplitude4.220Historical Low19.349Avg Price1Lot Size
About Nurix Therapeutics Company
Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in San Francisco, CA.
Company Profile
SymbolNRIX
Company NameNurix Therapeutics
Listing DateJul 24, 2020
Issue Price19.00
Founded2009
CEODr. Arthur T. Sands, M.D.,PhD
MarketNASDAQ
Employees284
Fiscal Year Ends11-30
Address1700 Owens Street,Suite 205
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94158
Phone1-415-660-5320
Websitehttp://www.nurixtx.com
Company Executives
- Name
- Position
- Salary
- Dr. Arthur T. Sands, M.D.,PhD
- Director, President and Chief Executive Officer
- 4.36M
- Dr. Gwenn Hansen, PhD
- Chief Scientific Officer
- 1.63M
- Dr. Christine Ring, J.D.,PhD
- Chief Legal Officer, Chief Compliance Officer and Secretary
- --
- Hans van Houte
- Chief Financial Officer and Principal Accounting Officer
- 1.61M
- Dr. David L. Lacey, M.D.
- Chairman of the Board
- 263.29K
- Anil Kapur
- Director
- --
- Paul M. Silva
- Independent Director
- 225.79K
- Judith A. Reinsdorf, J.D.
- Independent Director
- 225.79K
- Dr. Lori Anne Kunkel, M.D.
- Independent Director
- 228.29K
- Julia P. Gregory
- Independent Director
- 238.29K
- Edward C. Saltzman
- Independent Director
- 223.29K
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.